TG Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
AbbVie USD 4.35B 344M 2025-06
Alaunos Therapeutics 0 18K 2024-09
Amgen USD 2.6B 507M 2025-03
Ardelyx USD 18.26M 2.54M 2024-12
Bayer EUR 5.62B 98M 2025-03
Biogen USD 605M 24.3M 2025-06
Corcept Therapeutics USD 3.43M 1.03M 2025-06
Dynavax Technologies USD 14.04M 13.5M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
J&J USD 7.6B 304M 2025-06
Novartis USD 3.32B 95M 2025-06
PTC Therapeutics USD 15.48M 2.62M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
TG Therapeutics USD 18.94M 3.4M 2025-06
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06


TG Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.